Statins-induced myopathy and neuropathy are more pronounced in diabetes who suffer from peripheral neuropathy. Lipid-lowering drugs are indispensable for cardiovascular protection in diabetes. Myopathy is the principal reason for statins non non-adherence and /or discontinuation. This study aims to answer what is the rate of incidence does statin-induced undesirable effects myopathy affecting diabetes, especially those with complications such as neuropathy which aggravates it, etiology and best management (and alternatives ) to profit statins' benefits, overcoming their risks.
(2021). Statins Induced Myopathy Among Diabetes with Peripheral Neuropathy: Incidence, Etiology and Management. Egyptian Society of Diabetes and Lipidology Journal, 1(1), -. doi: 10.21608/esdlj.2021.455584
MLA
. "Statins Induced Myopathy Among Diabetes with Peripheral Neuropathy: Incidence, Etiology and Management", Egyptian Society of Diabetes and Lipidology Journal, 1, 1, 2021, -. doi: 10.21608/esdlj.2021.455584
HARVARD
(2021). 'Statins Induced Myopathy Among Diabetes with Peripheral Neuropathy: Incidence, Etiology and Management', Egyptian Society of Diabetes and Lipidology Journal, 1(1), pp. -. doi: 10.21608/esdlj.2021.455584
VANCOUVER
Statins Induced Myopathy Among Diabetes with Peripheral Neuropathy: Incidence, Etiology and Management. Egyptian Society of Diabetes and Lipidology Journal, 2021; 1(1): -. doi: 10.21608/esdlj.2021.455584
)
